Decreased natural killer (NK) cell function in chronic NK cell lymphocytosis associated with decreased surface expression of CD11b

Clinical Immunology

Volumn 99, Issue 1, 2001, Pages 53-64

  Orange, Jordan S ^a   Chehimi, Jihed ^a   Ghavimi, Darlene ^a   Campbell, Donald ^a   Sullivan, Kathleen E ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

CD11b; Cytotoxicity; IL 12; IL 2; Large granular lymphocytes; Natural killer cells; Perforin

Indexed keywords

CD11B ANTIGEN; CD16 ANTIGEN; CD3 ANTIGEN; CD56 ANTIGEN; CD57 ANTIGEN; CD8 ANTIGEN; CYTOKINE RECEPTOR; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 12; INTERLEUKIN 2; LIPOCORTIN 5; MESSENGER RNA; METHOTREXATE; PERFORIN;

APOPTOSIS; ARTICLE; CASE REPORT; CHILD; CONTROLLED STUDY; CROSS LINKING; CYTOKINE PRODUCTION; CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE; HUMAN; HUMAN CELL; LYMPHOCYTOSIS; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL;

EID: 0035047826     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1006/clim.2001.5002     Document Type: Article

References (39)

1. In vitro responsiveness to interleukins and theophylline of CD16+, CD56- natural killer cells in a patient with chronic granular lymphocyte disorder
2. Natural killer cells in antiviral defense: Function and regulation by innate cytokines
3. Functional and phenotypic assessment of neonatal human leucocytes expressing natural killer cell-associated antigens
4. Nonnasal lymphoma expressing the natural killer cell marker CD56: A clinicopathologic study of 49 cases of an uncommon aggressive neoplasm
5. Large granular lymphocyte proliferation with the natural killer-cell phenotype
6. Heterogeneity of large granular lymphocyte proliferations: Delineation of two major subtypes
7. Enhancing effect of natural killer cell stimulatory factor (NKSF/interleukin-12) on cell-mediated cytotoxicity against tumor-derived and virus-infected cells
8. Immunophenotyping of blood lymphocytes in childhood
9. Aggressive natural killer cell leukemia/lymphoma
10. Cord blood CD16+56- cells with low lytic activity are possible precursors of mature natural killer cells
11. Cord blood natural killer cells are functionally and phenotypically immature but readily respond to interleukin-2 and interleukin- 12
12. Leukocyte adhesion: CD11/CD 18 integrins and intercellular adhesion molecules
13. Pure red-cell aplasia associated with clonal expansion of granular lymphocytes expressing killer-cell inhibitory receptors
14. Natural killer-type receptors for HLA class I antigens are clonally expressed in lymphoproliferative disorders of natural killer and T-cell type
15. Cytokine levels in aggressive natural killer cell leukemia and malignant histiocytosis
16. Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo
17. The genetic deficiency of leukocyte surface glycoprotein Mac-1, LFA-1, p150,95 in humans is associated with defective antibody-dependent cellular cytotoxicity in vitro and defective protection against herpes simplex virus infection in vivo
18. Dysregulation of CD95/CD95 ligand-apoptotic pathway in CD3(+) large granular lymphocyte leukemia
19. Current concepts: Large granular lymphocyte leukemia
20. CD16+ NK lymphoproliferative disorders: Cellular and molecular characterization
21. Depressed natural killer (NK) function in blood and marrow is related to the decrease in CD11+ cells in acute leukemia
22. Comparative studies of human FcRIII-positive and negative natural killer cells
23. Clonal studies of CD3- lymphoproliferative disease of granular lymphocytes
24. Gene expression and secretion of cytokines and cytokine receptors from highly purified CD56+ natural killer cells stimulated with interleukin-2, interleukin-7 and interleukin-12
25. Hemophagocytic syndrome associated with aggressive natural killer cell leukemia
26. Receptor-induced death in human natural killer cells: Involvement of CD16
27. Clinical course and prognosis of the lymphoproliferative disease of granular lymphocytes. A multicenter study
28. A long-term study of patients with chronic natural killer cell lymphocytosis
29. Transient and persistent expansions of large granular lymphocytes (LGL) and NK-associated (NKa) cells: The Yorkshire Leukaemia Group Study
30. Natural killer cells and natural killer T cells
31. The lymphoproliferative disease of granular lymphocytes: Updated criteria for diagnosis
32. Physical and functional association of LFA-1 with DNAM-1 adhesion molecule
33. Development of human T and natural killer cells
34. Chronic natural killer cell lymphocytosis
35. Chronic natural killer cell lymphocytosis: A descriptive clinical study
36. Studies in listeriosis show the strong symbiosis between the innate cellular system and the T-cell response
37. The role of natural killer cells in immune surveillance of cancer
38. Development of natural killer cytotoxicity during childhood: Marked increases in number of natural killer cells with adequate cytotoxic abilities during infancy to early childhood
39. Cell-mediated immunity to Toxoplasma gondii: Initiation, regulation and effector function